X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (332) 332
deferoxamine (316) 316
animals (282) 282
index medicus (203) 203
male (188) 188
female (148) 148
iron (138) 138
deferoxamine - pharmacology (134) 134
desferrioxamine (134) 134
deferoxamine - therapeutic use (120) 120
deferiprone (116) 116
mice (115) 115
iron chelating agents - therapeutic use (111) 111
rats (109) 109
deferoxamine - pharmacokinetics (105) 105
iron - metabolism (99) 99
pharmacology & pharmacy (94) 94
tissue distribution (88) 88
hematology (86) 86
iron overload - drug therapy (78) 78
adult (76) 76
iron chelating agents - pharmacology (74) 74
deferasirox (70) 70
thalassemia (68) 68
deferoxamine - chemistry (67) 67
iron overload (67) 67
pharmacokinetics (67) 67
deferoxamine - administration & dosage (66) 66
biochemistry & molecular biology (65) 65
therapy (59) 59
toxicity (58) 58
iron chelating agents - pharmacokinetics (57) 57
overload (57) 57
chelation therapy (56) 56
pyridones - therapeutic use (52) 52
iron - pharmacokinetics (51) 51
iron chelating agents - administration & dosage (51) 51
adolescent (47) 47
beta-thalassemia (47) 47
oncology (45) 45
toxicology (44) 44
chelating agents (43) 43
cell line, tumor (42) 42
iron chelation (42) 42
iron overload - etiology (42) 42
middle aged (42) 42
iron chelating agents - adverse effects (41) 41
liver (41) 41
safety (41) 41
chelation (40) 40
liver - metabolism (39) 39
cancer (38) 38
deferoxamine - metabolism (38) 38
administration, oral (37) 37
benzoates - therapeutic use (37) 37
triazoles - therapeutic use (37) 37
beta-thalassemia - drug therapy (36) 36
ferritin (36) 36
iron chelating agents - chemistry (36) 36
dose-response relationship, drug (35) 35
analysis (34) 34
oxidative stress (34) 34
rats, sprague-dawley (34) 34
chelation-therapy (32) 32
thalassemia major (32) 32
transfusion reaction (32) 32
aluminum (31) 31
child (31) 31
drug therapy, combination (31) 31
ferritins - blood (31) 31
icl670 (31) 31
kinetics (31) 31
aluminum - pharmacokinetics (30) 30
deferoxamine - adverse effects (30) 30
treatment outcome (30) 30
iron - blood (29) 29
positron-emission tomography - methods (29) 29
metabolism (28) 28
mice, nude (28) 28
cells, cultured (27) 27
complications (27) 27
expression (27) 27
pharmacology (26) 26
pyridones - pharmacokinetics (26) 26
radioisotopes (26) 26
beta-thalassemia major (25) 25
medicine & public health (25) 25
pyridones - administration & dosage (25) 25
time factors (25) 25
cells (24) 24
chelating agents - pharmacology (24) 24
chemistry, medicinal (24) 24
disease models, animal (24) 24
efficacy (24) 24
pyridones - pharmacology (24) 24
iron chelators (23) 23
multidisciplinary sciences (23) 23
radiology, nuclear medicine & medical imaging (23) 23
tomography (23) 23
zirconium - chemistry (23) 23
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (594) 594
Japanese (3) 3
German (2) 2
Italian (2) 2
Spanish (2) 2
French (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 12/2013, Volume 88, Issue 12, pp. 1068 - 1073
.... We also report, for the first time, the safety and pharmacokinetics of deferasirox in patients concomitantly receiving hydroxyurea. Deferasirox (n = 135) and DFO (n = 68... 
SURVIVAL | BIOMARKERS | SUPPORT | B-CELL | MONOCYTE COUNT | R-CHOP | RITUXIMAB | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | CHEMOTHERAPY | ABSOLUTE LYMPHOCYTE COUNT | Benzoates - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Benzoates - therapeutic use | Prospective Studies | Iron Overload - drug therapy | Humans | Middle Aged | Child, Preschool | Deferoxamine - therapeutic use | Male | Anemia, Sickle Cell - drug therapy | Deferoxamine - administration & dosage | Deferoxamine - adverse effects | Iron Overload - etiology | Young Adult | Ferritins - blood | Adult | Deferoxamine - pharmacokinetics | Female | Triazoles - pharmacokinetics | Acute Kidney Injury - chemically induced | Iron Chelating Agents - administration & dosage | Drug Therapy, Combination | Child | Chemical and Drug Induced Liver Injury - etiology | Triazoles - therapeutic use | Iron Chelating Agents - therapeutic use | Chelation Therapy - adverse effects | Hydroxyurea - administration & dosage | Benzoates - administration & dosage | Iron Chelating Agents - adverse effects | Transfusion Reaction | Cellulitis - chemically induced | Anemia, Sickle Cell - therapy | Hydroxyurea - adverse effects | Hydroxyurea - pharmacokinetics | Adolescent | Hydroxyurea - therapeutic use | Anemia, Sickle Cell - blood | Iron Chelating Agents - pharmacokinetics | Benzoates - pharmacokinetics | Hydroxyurea | Sickle cell anemia | Comparative analysis | Gastrointestinal diseases | Ferritin
Journal Article
Biomaterials, ISSN 0142-9612, 2016, Volume 102, pp. 58 - 71
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2015, Volume 201, pp. 68 - 77
Journal Article
Journal of cerebral blood flow and metabolism, ISSN 1559-7016, 2017, Volume 37, Issue 9, pp. 3110 - 3123
Journal Article
European journal of nuclear medicine and molecular imaging, ISSN 1619-7089, 2009, Volume 37, Issue 2, pp. 250 - 259
Journal Article
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 03/2017, Volume 15, Issue 3, pp. 565 - 574
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2015, Volume 112, Issue 52, pp. 15850 - 15855
Journal Article